Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-18 Purchase | 2024-11-18 4:20 pm | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 20,000 | $4.44 | $88,800 | 940,003 (Direct) | View |
| 2024-11-11 Sale | 2024-11-13 4:58 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 2,400 | $5 | $12,000 | 15,202,352 (Direct) | View |
| 2024-11-11 Sale | 2024-11-13 4:57 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 2,400 | $5 | $12,000 | 14,291,336 (Direct) | View |
| 2024-11-06 Purchase | 2024-11-07 6:57 pm | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 39,360 | $4.7988 | $188,881 | 920,003 (Direct) | View |
| 2024-11-06 Purchase | 2024-11-07 6:56 pm | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 41,880 | $4.737 | $198,386 | 41,880 (Direct) | View |
| 2024-11-01 Sale | 2024-11-05 5:41 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 141,032 | $4.3866 | $618,658 | 15,204,752 (Direct) | View |
| 2024-11-01 Sale | 2024-11-05 5:40 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 129,672 | $4.3833 | $568,387 | 14,293,736 (Direct) | View |
| 2024-10-24 Sale | 2024-10-25 7:55 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 144,560 | $4.3772 | $632,761 | 13,669,360 (Direct) | View |
| 2024-10-23 Sale | 2024-10-25 7:54 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 144,816 | $4.3773 | $633,896 | 14,591,736 (Direct) | View |
| 2024-10-18 Sale | 2024-10-22 8:46 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 514,152 | $4.3824 | $2,253,237 | 14,736,552 (Direct) | View |
| 2024-10-18 Sale | 2024-10-22 8:45 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 525,768 | $4.3817 | $2,303,773 | 13,813,920 (Direct) | View |
| 2024-09-11 Sale | 2024-09-13 4:15 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 600,000 | $3.7572 | $2,254,320 | 15,250,704 (Direct) | View |
| 2024-09-11 Sale | 2024-09-13 4:15 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 600,000 | $3.7568 | $2,254,080 | 14,339,688 (Direct) | View |
| 2024-08-12 Sale | 2024-08-14 4:16 pm | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 400,000 | $3.2017 | $1,280,689 | 15,850,704 (Direct) | View |
| 2024-08-12 Sale | 2024-08-14 4:15 pm | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 400,000 | $3.2014 | $1,280,548 | 14,939,688 (Direct) | View |
| 2024-08-12 Purchase | 2024-08-14 4:15 pm | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 36,000 | $2.87 | $103,320 | 880,643 (Direct) | View |
| 2024-05-03 Sale | 2024-05-03 7:21 pm | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 36,248 | $1.9596 | $71,032 | 2,621,552 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-01 Tax Withholding | 2024-11-01 7:19 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 245,952 | $4.2412 | 15,345,784 (Direct) | View |
| 2024-10-30 Option Award | 2024-11-01 7:19 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 1,000,000 | $0 | 15,345,784 (Direct) | View |
| 2024-11-01 Tax Withholding | 2024-11-01 7:17 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 65,936 | $4.2412 | 2,911,480 (Direct) | View |
| 2024-10-30 Option Award | 2024-11-01 7:17 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 350,000 | $0 | 2,911,480 (Direct) | View |
| 2024-11-01 Tax Withholding | 2024-11-01 7:14 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 245,952 | $4.2412 | 14,423,408 (Direct) | View |
| 2024-10-30 Option Award | 2024-11-01 7:14 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 1,000,000 | $0 | 14,423,408 (Direct) | View |
| 2024-10-30 Option Award | 2024-11-01 7:13 pm | N/A N/A | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-08-07 Option Award | 2024-08-09 7:13 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 800,000 | $0 | 16,250,704 (Direct) | View |
| 2024-08-07 Tax Withholding | 2024-08-09 7:13 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 314,800 | $2.62 | 16,250,704 (Direct) | View |
| 2024-08-07 Option Award | 2024-08-09 7:12 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 200,000 | $0 | 2,627,416 (Direct) | View |
| 2024-08-07 Tax Withholding | 2024-08-09 7:12 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 87,904 | $2.62 | 2,627,416 (Direct) | View |
| 2024-08-07 Option Award | 2024-08-09 7:11 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 800,000 | $0 | 15,339,688 (Direct) | View |
| 2024-08-07 Tax Withholding | 2024-08-09 7:11 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 314,800 | $2.62 | 15,339,688 (Direct) | View |
| 2024-08-01 Tax Withholding | 2024-08-05 9:30 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 88,544 | $2.8325 | 14,854,488 (Direct) | View |
| 2024-08-01 Tax Withholding | 2024-08-05 9:29 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 88,544 | $2.8325 | 15,765,504 (Direct) | View |
| 2024-08-01 Tax Withholding | 2024-08-05 9:28 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 106,232 | $2.8325 | 2,515,320 (Direct) | View |
| 2024-05-01 Tax Withholding | 2024-05-03 7:23 pm | N/A N/A | Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer | 88,544 | $1.9313 | 14,943,032 (Direct) | View |
| 2024-05-01 Tax Withholding | 2024-05-03 7:21 pm | N/A N/A | Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer | 73,824 | $1.9313 | 2,621,552 (Direct) | View |
| 2024-05-01 Tax Withholding | 2024-05-03 7:19 pm | N/A N/A | Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO | 88,544 | $1.9313 | 15,854,048 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:18 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | Sinha Vikas Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:17 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | Edwards Martin Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:17 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | Ullman Anders Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:17 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | EBSWORTH DAVID R Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:17 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:17 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | SHAH MAHENDRA Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:16 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | Cunningham Kenneth Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:15 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | Brady James Aloysius Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-29 Option Award | 2024-04-30 4:15 pm | N/A 2034-04-28 | Verona Pharma plc | VRNA | Deschamps Lisa Director | 240,000 | $0 | 240,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-02 4:15 pm | N/A 2034-03-31 | Verona Pharma plc | VRNA | Fisher Andrew General Counsel | 2,400,000 | $0 | 2,400,000 (Direct) | View |